Skip to main content
main-content

Video commentaries

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.


Expert commentaries from clinicians and researchers on clinical studies, guidelines, and topical issues in rheumatology.

EULAR 2019

15-06-2019 | Psoriatic arthritis | EULAR 2019 | Article

Expert commentary: The SPIRIT-H2H trial

Laura Coates discusses why the results of the SPIRIT-H2H trial are important for clinical practice (2:41).

15-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article

Expert commentary: The FINCH 1 trial

Roy Fleischmann gives his perspective on the FINCH 1 trial results (1:58)

14-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article

Researcher comment: The ORAL Shift trial

Stanley Cohen discusses the latest findings from the trial looking at methotrexate withdrawal in patients with rheumatoid arthritis achieving low disease activity with tofacitinib (2:11).  

ACR/ARHP 2018

22-10-2018 | Giant cell arteritis | ACR/ARHP 2018 | Video

Axillary artery ultrasound proposed as first-line imaging test for large vessel giant cell arteritis

Berit Dalsgaard Nielsen discusses Aarhus University study findings showing the potential for ultrasound as a first-line imaging test for diagnosing large vessel inflammation in patients with suspected giant cell arteritis (4:57).

27-10-2018 | Denosumab | ACR/ARHP 2018 | Video

Support for denosumab as a treatment option for osteoporosis in patients treated with glucocorticoids

Kenneth Saag discusses his findings of a superior bone mineral density benefit at 2 years with denosumab versus risedronate in patients with glucocorticoid-related osteoporosis (4:45).

24-10-2018 | Cardiovascular disease | ACR/ARHP 2018 | Video

Looking to collaborative models of care to improve primary prevention of CVD in patients with inflammatory arthritis

Lihi Eder describes a new model of care based on collaboration between cardiologists and rheumatologists to better manage cardiovascular risk factors in patients with inflammatory arthritis (5:56).

EULAR 2018

15-06-2018 | Systemic lupus erythematosus | EULAR 2018 | Video

Expert commentary: Promising results with herpes zoster vaccine in SLE patients

Thomas Dörner comments on study results demonstrating that a live attenuated herpes zoster vaccine is well tolerated and provokes an antibody response in patients with SLE (5:14).

Read the accompanying news story here

14-06-2018 | TNF inhibitors | EULAR 2018 | Video

Researcher comment: Role of TNF inhibitors on need for joint replacement in RA

​​​​​​​Samuel Hawley comments on his research findings showing that TNF inhibitors might not play as big a role in the recent reduction in joint replacement procedures in patients with RA as originally thought and that additional factors are likely to be involved. (2:59)

Read the related news story

14-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Expert commentary: COBRA trial 23-year follow-up analysis on mortality rates

Elena Nikiphorou provides her thoughts on the findings of this trial showing a normalization of mortality in patients with rheumatoid arthritis receiving early, intensive treatment (2:41).

Read the accompanying news story here.

BSR 2018

03-05-2018 | Juvenile idiopathic arthritis | Conferences | Video

Managing JIA-associated uveitis: The SHARE recommendations

In this video, Athimalaipet Ramanan gives an overview of the key points from the SHARE initiative consensus recommendations on the screening, diagnosis, and management of juvenile idiopathic arthritis-associated uveitis.

ACR/ARHP 2017

07-11-2017 | ACR/ARHP 2017 | Video

The effects of obesity on the outcomes of rheumatic disorders

Margaret Tsai provides independent comment on three studies exploring the effects of obesity in patients with rheumatic diseases.

08-11-2017 | Osteoporosis | ACR/ARHP 2017 | Video

Expert commentary: Bisphosphonate drug holidays and fracture risk

Linda Russell gives an independent comment on a study showing that suspending bisphosphonate treatment for more than 2 years is associated with increased fracture risk.

Read the accompanying news story

08-11-2017 | Axial spondyloarthritis | ACR/ARHP 2017 | Video

Expert commentary: The ABILITY-3 trial

Walter Maksymowych comments on the ABILITY-3 trial results showing that continued adalimumab treatment is important for the maintenance of remission among patients with nonradiographic axial spondyloarthritis.

Read the accompanying news story

EULAR 2017

16-06-2017 | Psoriatic arthritis | EULAR 2017 | Video

EULAR 2017 highlights: Philip Mease

Medicine Matters rheumatology editorial board member Philip Mease summarizes research on new therapeutic agents for psoriatic arthritis presented at the meeting.

This activity is financially supported by Novartis Pharma AG.

17-06-2017 | EULAR 2017 | Video

EULAR 2017 highlights: Roy Fleischmann

Roy Fleischmann discusses his highlights from the rheumatoid arthritis presentations, including the results from the ORAL Strategy trial.

This activity is financially supported by Novartis Pharma AG

16-06-2017 | EULAR 2017 | Video

EULAR 2017 highlights: Jürgen Braun

Jürgen Braun talks about his spondyloarthritis highlights from the EULAR meeting.

This activity is financially supported by Novartis Pharma AG.

Image Credits